Literature DB >> 12447347

Current multimodality management of medulloblastoma.

Arnold C Paulino1.   

Abstract

Entities:  

Mesh:

Year:  2002        PMID: 12447347     DOI: 10.1067/mcn.2002.130267

Source DB:  PubMed          Journal:  Curr Probl Cancer        ISSN: 0147-0272            Impact factor:   3.187


× No keyword cloud information.
  5 in total

1.  Appraisal of the current staging system for residual medulloblastoma by volumetric analysis.

Authors:  Dimitris Kombogiorgas; Stephanie Puget; Nathalie Boddaert; Andrew Peet; Martin English; Kal Natarajan; Jacques Grill; Dominique Couanet; Christian Sainte-Rose; Spyros Sgouros
Journal:  Childs Nerv Syst       Date:  2011-08-04       Impact factor: 1.475

2.  WIP1 enhances tumor formation in a sonic hedgehog-dependent model of medulloblastoma.

Authors:  Tiffany A Doucette; Yuhui Yang; Carolyn Pedone; John Y H Kim; Adrian Dubuc; Paul D Northcott; Michael D Taylor; Daniel W Fults; Ganesh Rao
Journal:  Neurosurgery       Date:  2012-04       Impact factor: 4.654

3.  Cerebellopontine angle medulloblastoma with extensive nodularity in a child: case report and review of the literature.

Authors:  Raywat Noiphithak; Vich Yindeedej; Chatchai Thamwongskul
Journal:  Childs Nerv Syst       Date:  2016-12-24       Impact factor: 1.475

Review 4.  SHH desmoplastic/nodular medulloblastoma and Gorlin syndrome in the setting of Down syndrome: case report, molecular profiling, and review of the literature.

Authors:  Ross Mangum; Elizabeth Varga; Daniel R Boué; David Capper; Martin Benesch; Jeffrey Leonard; Diana S Osorio; Christopher R Pierson; Nicholas Zumberge; Felix Sahm; Daniel Schrimpf; Stefan M Pfister; Jonathan L Finlay
Journal:  Childs Nerv Syst       Date:  2016-07-21       Impact factor: 1.475

5.  Medulloblastoma in China: clinicopathologic analyses of SHH, WNT, and non-SHH/WNT molecular subgroups reveal different therapeutic responses to adjuvant chemotherapy.

Authors:  Zhen-Yu Zhang; Jian Xu; Yong Ren; Kay Ka-Wai Li; Ho-Keung Ng; Ying Mao; Ping Zhong; Yu Yao; Liang-Fu Zhou
Journal:  PLoS One       Date:  2014-06-16       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.